Business
Marijuana MSOs expand Florida retail, betting on adult-use legalization
Multistate operators are busy expanding their retail footprints in Florida’s nearly $2 billion medical marijuana market, in some cases betting that adult-use legalization is on the horizon and jostling into position to capitalize on that possibility.
But investing in Florida marijuana retail could be a gamble.
Medical cannabis dispensaries are already offering deep discounts to the more than 800,000 registered medical consumers in the increasingly competitive Florida market, and some companies reported flat sales in the state for the quarter ending June 30.
Also, more competition is on the way.
There are 22 companies currently licensed in Florida’s medical market, which is one of the nation’s largest, in addition to two licenses that were recently awarded to Black cultivators.
Regulators are currently reviewing license applications for a new batch of 22 vertically integrated Medical Marijuana Treatment Centers (MMTCs) – as MMJ operators in Florida are known.
Adult-use legalization is hardly guaranteed, what with the Florida attorney general trying to block an effort by the state’s largest MMJ operator to put the issue as it’s currently worded before voters in November 2024.
But that’s hardly put a damper on MMJ companies deciding to open new retail outlets.
In July, Chicago-based Verano Holdings celebrated the opening of its 70th dispensary, placing the MSO in the No. 2 spot in store counts behind Florida-based Trulieve Cannabis and ahead of No. 3 Ayr Wellness and No. 4 Curaleaf Holdings.
New York-based Curaleaf, for its part, plans to expand further into the state this year.
And Miami-based Ayr said it has met its goal of opening 10 new dispensaries in the state in 2023.
The company plans to open another two to four dispensaries before the end of the year.
Even Trulieve, long the market leader in the state, is still expanding, adding three more stores to its portfolio so far this year and bringing its total number to 126 as of Aug. 11, according to the Florida Department of Health’s Office of Medical Marijuana Use (OMMU).
Florida regulators limit the number of MMTC licenses, but there’s no cap on the number of dispensaries licensees can open.
And even though the deep discounts and promotions offered to consumers by retailers can be a sign of a saturated market, representatives of operators say they haven’t reached the store-saturation point – especially if the state legalizes adult-use sales.
Too many dispensaries?
Verano’s sales in Florida for the quarter ending June 30 were flat year-over-year – and CEO George Archos said during the company’s Aug. 8 earnings call he was pleased with that result.
That’s because the company hasn’t participated in the kinds of deep discounts and promotions other stores are offering consumers in the oversupplied market, Darren Weiss, the company’s president, said in an interview with MJBizDaily.
Weiss said that his team’s analysis shows that as more stores open, each one is taking a “smaller piece of the pie.”
But over the long term, new stores do drive growth and are accretive to the portfolio, he added.
“But whereas it used to be that, within three to six months of store openings, you are really seeing that type of accretion, now that takes about a year,” he said.
In an email to MJBizDaily, Curaleaf CEO Matt Darin said the company will continue to expand its Florida footprint, which already includes 60 dispensaries, through 2023.
Darin also said the company chose not to match some of the discounts it sees, instead choosing to add new products and brands to the roster.
“Rather, we have taken proactive measures to organically increase our store traffic through an expanded product assortment, including Select Briq and Select Liquid Diamonds, as well as targeted marketing initiatives,” Darin said, referring to vape and high-potency oil products.
“We are pleased that these measures are already yielding positive results.”
Similarly, Ayr is expanding its product portfolio, most recently adding edibles brand Kiva Confections to its lineup in its Florida stores.
Verano’s Weiss and an Ayr spokesperson also said their Florida stores haven’t discounted products to the same degree as some competitors.
However, Verano and Ayr – in addition to Trulieve – all offer regular sales and promotions to shoppers, according to MMJ discount tracking website FLCannabisDeals.
Meanwhile, the medical cannabis market is still growing, albeit at a slower pace than last year.
The 2023 MJBiz Factbook projects Florida’s medical cannabis market will grow from $1.75 billion in 2023 to $2.4 billion by 2026.
Registered active patient numbers have increased by more than 7% since January, from 781,354 to 838,470, according to the OMMU.
Adult-use legalization uncertain
Expanding in state medical marijuana markets to prepare for forthcoming, larger adult-use markets is a well-worn strategy for cannabis operators.
Just recently in Maryland, for example, MMJ operators scrambled to acquire or open dispensaries in time for adult-use sales to launch July 1.
But it’s unclear if voters in Florida will have the opportunity to vote on the issue in November of next year – and, if they do, whether they would approve recreational marijuana.
Trulieve donated nearly $40 million toward the Smart & Safe Florida adult-use legalization campaign.
The group collected more than 900,000 signatures – more than enough to put the amendment on the ballot in November 2024.
The amendment “allows adults 21 years or older to possess, purchase, or use marijuana products and marijuana accessories for non-medical personal consumption by smoking, ingestion, or otherwise.”
But according to documents filed with the state Supreme Court, the attorney general, the Florida Chamber of Commerce and the Drug Free America Foundation are trying to block the effort, calling it unconstitutional and accusing Trulieve of trying to have a “monopolistic stranglehold” on the adult-use market.
The group also argued that the amendment invites Floridians to violate federal law and misleads voters into thinking that sales would be allowed by others who aren’t already licensed MMTCs.
Trulieve, in a statement to WUSF Public Media, disputed the arguments.
“The ballot language is clear, states the chief purpose of the amendment and – without a doubt – covers one and only one subject,” Trulieve said.
“For these reasons, we trust the court will agree that the voters of Florida should have the opportunity to vote to allow adults in Florida the freedom to use cannabis for their personal consumption.”
The uncertainty is why Weiss said Verano isn’t necessarily banking on adult use launching in Florida and is instead focusing on MMJ, which made up 25% of the company’s consolidated sales last year, according to the operator’s financial results for 2022.
“We’re building our business to be sustainable in the (MMJ) market,” Weiss said.
Ayr, by contrast, is wagering on a recreational market.
“We’re looking at dispensaries more in terms of the future adult-use market, and many of the stores we’re opening are strategically positioned for the adult-use future,” the Ayr spokesperson said.
Miami-Dade and Broward counties aren’t large medical cannabis markets, for example, the spokesperson added.
But the company is betting that its new stores in those areas will be fruitful investments if and when the state legalizes adult-use sales.
“We strive to be the neighborhood dispensary that is ingrained in the local community and offers a unique, personalized experience to every patient and customer that enters,” the Ayr spokesperson said.
Source: https://mjbizdaily.com/marijuana-msos-expand-florida-retail-betting-on-adult-use-legalization/
Business
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Business
Marijuana companies suing US attorney general in federal prohibition challenge
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Business
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
-
Business1 year ago
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business1 year ago
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business1 year ago
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year ago
Washington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business1 year ago
Marijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year ago
Legal Marijuana Handed A Nothing Burger From NY State
-
Business1 year ago
Can Cannabis Help Seasonal Depression
-
Blogs1 year ago
Cannabis Art Is Flourishing On Etsy